Codeine (Medication) → Saudi Arabia

Codeine-containing medications require an SFDA import permit when the cumulative dose exceeds 200 mg.

Details

The Saudi Food and Drug Authority (SFDA) classifies codeine as a controlled substance (Schedule II opioid) under the Pharmaceutical Products Regulations and the Saudi Narcotics Control framework. Travellers carrying codeine-containing medications (e.g., co-codamol, codeine phosphate syrup) with a cumulative dose exceeding 200 mg must obtain a prior import permit from the SFDA before arriving in Saudi Arabia. For quantities within 200 mg cumulative, a valid prescription from a licensed physician is required and must be carried with the medication. ZATCA customs officers may confiscate medications that are not accompanied by correct documentation.

Quantity limit

≤200 mg cumulative codeine content with valid prescription; >200 mg requires SFDA import permit

Documentation required

• Valid physician's prescription
• SFDA import permit for cumulative doses >200 mg
• Medication in original pharmacy packaging

Legal reference

Saudi Narcotics Control Law (Royal Decree M/39); SFDA Pharmaceutical Products Regulations; ZATCA controlled medication import guidelines

Surrender at customs

Saudi ZATCA accepts voluntary surrender of controlled medications at King Abdulaziz International Airport and other POEs. Declare at the Red Channel. Written abandonment request accepted. Proactive surrender significantly reduces risk of prosecution under Saudi Controlled Substances Act.

Practical advice

Apply for an SFDA import permit well before travel if your codeine prescription exceeds the threshold. Carry all medications in original labelled packaging with the prescription and doctor's letter. Declare at the red channel.

Customs authority

Zakat, Tax and Customs Authority (ZATCA) · https://www.zatca.gov.sa